Mesenchymal stem cell therapy reduces inflammation and damage in a model of chronic lung disease

Doherty Declan (Belfast, United Kingdom)

Source: ERS Lung Science Conference 2017
Number: 16
Disease area: Airway diseases

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Doherty Declan (Belfast, United Kingdom). Mesenchymal stem cell therapy reduces inflammation and damage in a model of chronic lung disease. ERS Lung Science Conference 2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: